These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25769925)

  • 21. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
    Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
    J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.
    Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
    Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
    Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
    Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
    Wong M; La Cava A; Singh RP; Hahn BH
    J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
    Fife BT; Guleria I; Gubbels Bupp M; Eagar TN; Tang Q; Bour-Jordan H; Yagita H; Azuma M; Sayegh MH; Bluestone JA
    J Exp Med; 2006 Nov; 203(12):2737-47. PubMed ID: 17116737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface.
    Meggyes M; Miko E; Szigeti B; Farkas N; Szereday L
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):74. PubMed ID: 30782114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment.
    Zippelius A; Schreiner J; Herzig P; Müller P
    Cancer Immunol Res; 2015 Mar; 3(3):236-44. PubMed ID: 25623164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization.
    Rekoske BT; Smith HA; Olson BM; Maricque BB; McNeel DG
    Cancer Immunol Res; 2015 Aug; 3(8):946-55. PubMed ID: 26041735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
    Kobold S; Grassmann S; Chaloupka M; Lampert C; Wenk S; Kraus F; Rapp M; Düwell P; Zeng Y; Schmollinger JC; Schnurr M; Endres S; Rothenfußer S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26105028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
    Linedale R; Schmidt C; King BT; Ganko AG; Simpson F; Panizza BJ; Leggatt GR
    PLoS One; 2017; 12(4):e0175755. PubMed ID: 28423034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.
    Tewalt EF; Cohen JN; Rouhani SJ; Guidi CJ; Qiao H; Fahl SP; Conaway MR; Bender TP; Tung KS; Vella AT; Adler AJ; Chen L; Engelhard VH
    Blood; 2012 Dec; 120(24):4772-82. PubMed ID: 22993390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
    Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
    J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed death ligand-1 expression and memory T-cell generation in Coxiella burnetii infection.
    Ka MB; Bechah Y; Olive D; Mege JL
    Microb Pathog; 2015 Mar; 80():1-6. PubMed ID: 25680834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.
    Ansari MJ; Salama AD; Chitnis T; Smith RN; Yagita H; Akiba H; Yamazaki T; Azuma M; Iwai H; Khoury SJ; Auchincloss H; Sayegh MH
    J Exp Med; 2003 Jul; 198(1):63-9. PubMed ID: 12847137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
    Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX
    Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.
    Gianchecchi E; Delfino DV; Fierabracci A
    Autoimmun Rev; 2013 Sep; 12(11):1091-100. PubMed ID: 23792703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction.
    Huang CT; Huso DL; Lu Z; Wang T; Zhou G; Kennedy EP; Drake CG; Morgan DJ; Sherman LA; Higgins AD; Pardoll DM; Adler AJ
    J Immunol; 2003 Apr; 170(8):3945-53. PubMed ID: 12682221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.